| Code | 1158F | ||||||||||
| MA number | EU/1/25/1947/002 | ||||||||||
| Product Form: | cps end 14x174 mg (fľ.HDPE) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Neuraxpharm Pharmaceuticals, S.L. , Spain | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 30 | ||||||||||
| Route of admin.: | Oral use |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 28.07.2025 |
| Validity: | 28.07.2030 |
| SmPC + PL: |
European Medicines Agency's database
|
| Safety feature | Yes |
| Data update: | 19.09.2025 |
